探讨电复律或消融术时伴有心房颤动和/或房扑患者的抑郁症状和焦虑情况。
Exploring Depressive Symptoms and Anxiety Among Patients With Atrial Fibrillation and/or Flutter at the Time of Cardioversion or Ablation.
出版信息
J Cardiovasc Nurs. 2021;36(5):470-481. doi: 10.1097/JCN.0000000000000723.
BACKGROUND
Depression and anxiety in patients with atrial fibrillation (AF) and/or atrial flutter may influence the effectiveness of cardioversion and ablation. There is a lack of knowledge related to depressive symptoms and anxiety at the time of these procedures.
OBJECTIVE
We aimed to describe the prevalence and explore potential covariates of depressive symptoms and anxiety in patients with AF at the time of cardioversion or ablation. We further explored the influence of depressive symptoms and anxiety on quality of life at the time of procedure and 6-month AF recurrence.
METHODS
Depressive symptoms, anxiety, and quality of life were collected at the time of cardioversion or ablation using the Patient Health Questionnaire-9, State-Trait Anxiety Inventory, and Atrial Fibrillation Effect on Quality of Life questionnaire. Presence of AF recurrence within 6 months post procedure was evaluated.
RESULTS
Participants (N = 171) had a mean (SD) age of 61.20 (11.23) years and were primarily male (80.1%) and white, non-Hispanic (81.4%). Moderate to severe depressive symptoms (17.2%) and clinically significant state (30.2%) and trait (23.6%) anxiety were reported. Mood/anxiety disorder diagnosis was associated with all 3 symptoms. Atrial fibrillation symptom severity was associated with both depressive symptoms and trait anxiety. Heart failure diagnosis and digoxin use were also associated with depressive symptoms. Trends toward significance between state and trait anxiety and participant race/ethnicity as well as depressive symptoms and body mass index were observed. Study findings support associations between symptoms and quality of life, but not 6-month AF recurrence.
CONCLUSION
Depressive symptoms and anxiety are common in patients with AF. Healthcare providers should monitor patients with AF for depressive symptoms and anxiety at the time of procedures and intervene when indicated. Additional investigations on assessment, prediction, treatment, and outcome of depressive symptoms and anxiety in patients with AF are warranted.
背景
在心房颤动（AF）和/或心房扑动患者中，抑郁和焦虑可能会影响电复律和消融的效果。目前对这些操作时的抑郁症状和焦虑缺乏了解。
目的
我们旨在描述 AF 患者电复律或消融时抑郁症状和焦虑的患病率，并探讨其潜在的影响因素。我们还进一步探讨了抑郁症状和焦虑对操作时和 6 个月时 AF 复发时生活质量的影响。
方法
在电复律或消融时使用患者健康问卷-9、状态特质焦虑量表和心房颤动对生活质量问卷收集抑郁症状、焦虑和生活质量数据。评估术后 6 个月内 AF 复发的情况。
结果
参与者（N=171）的平均年龄（SD）为 61.20（11.23）岁，主要为男性（80.1%）和白人非西班牙裔（81.4%）。报告有中度至重度抑郁症状（17.2%）和临床显著的状态（30.2%）和特质（23.6%）焦虑。心境/焦虑障碍诊断与所有 3 种症状相关。房颤症状严重程度与抑郁症状和特质焦虑均相关。心力衰竭诊断和地高辛使用也与抑郁症状相关。状态和特质焦虑与参与者种族/民族以及抑郁症状和体重指数之间存在显著趋势。研究结果支持症状与生活质量之间的相关性，但与 6 个月时的 AF 复发无关。
结论
在 AF 患者中，抑郁症状和焦虑很常见。医疗保健提供者在进行操作时应监测 AF 患者的抑郁症状和焦虑，并在需要时进行干预。需要进一步研究评估、预测、治疗和 AF 患者抑郁症状和焦虑的结局。
Zotero 插件